Related references
Note: Only part of the references are listed.The inflammation in cutaneous lichen planus is dominated by IFN-Υ and IL-21-A basis for therapeutic JAK1 inhibition
Katharina Pietschke et al.
EXPERIMENTAL DERMATOLOGY (2021)
Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus
Aimee Coscarart et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
Lichenoid drug reaction due to anti-tubercular therapy presenting as erythroderma
Anusha Katare et al.
DERMATOLOGIC THERAPY (2020)
Lichenoid rash: A new side e ff ect of oral Cladribine
Francesco Aruta et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Lichenoid Reaction Caused by Antihistamines and Corticosteroids
Ketut Suryana
JOURNAL OF ASTHMA AND ALLERGY (2020)
European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology
D. Ioannides et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Black box warning rash with entecavir-case report
Xiong Khee Cheong et al.
BMC GASTROENTEROLOGY (2020)
Dermatological side effects rarely interfere with the continuation of checkpoint inhibitor immunotherapy for cancer
Jessica F. J. Rovers et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Blaschkoid Lichenoid Drug Eruption Due to Tenofovir
Rekha Virath et al.
INDIAN DERMATOLOGY ONLINE JOURNAL (2020)
A rare case report of apixaban-induced lichenoid eruption
Tanvi Patil et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2020)
Lichen planopilaris induced by infliximab: A case report
Meghan L. McPhie et al.
SAGE OPEN MEDICAL CASE REPORTS (2020)
Spectrum of cutaneous adverse drug reactions to anti-tubercular drugs and safe therapy after re-challenge - A retrospective study
Reena K. Sharma et al.
INDIAN DERMATOLOGY ONLINE JOURNAL (2020)
Combined immune therapy grade IV dermatitis in metastatic melanoma
Manreet Randhawa et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response
Jonathan L. Curry et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
Clinical epidemiology and treatment of lichen planus: A retrospective review of 2 tertiary care centers
Zachary Schwager et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptions
Robin Reschke et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2019)
Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features
Michael T. Tetzlaff et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus
Shuai Shao et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management
Emily Coleman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Resolution of Pembrolizumab-Associated Steroid-Refractory Lichenoid Dermatitis with Cyclosporine
Emma Fixsen et al.
ONCOLOGIST (2019)
Bilateral Lower Extremity Skin Eruptions in an HIV-Positive Man Receiving Pembrolizumab Monotherapy for Non-Small Cell Lung Cancer
Emily Boozalis et al.
JAMA ONCOLOGY (2019)
Cutaneous adverse drug reactions to targeted chemotherapeutic drugs: A clinico-epidemiological study
Kriteeka Saini et al.
INDIAN JOURNAL OF DERMATOLOGY (2019)
Denosumab-induced cutaneous hypersensitivity reaction with distinct clinical and histopathologic findings
Brian J. King et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
A dissimilar biosimilar? Lichenoid drug eruption induced by an infliximab biosimilar
N. Gonzalez et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Nivolumab-induced lichenoid dermatitis occurring in a patient with metastatic melanoma successfully treated with alitretinoin
C. Edwards et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2018)
Drug Eruption to Rosuvastatin With Recurrence on Simvastatin: A Case Report
Ian T. Y. Wong et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2018)
Granulomatous and lichenoid dermatitis after IgG4 anti-PD-1 monoclonal antibody therapy for advanced cancer
Julio A. Diaz-Perez et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features
Tsetan Dolkar et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Immune response patterns in non-communicable inflammatory skin diseases
K. Eyerich et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Lichenoid drug eruption associated with rifampicin
C. Ladhari et al.
PRESSE MEDICALE (2018)
Glibenclamide-induced photodistributed lichenoid eruption: An unusual association
Zohra Chadli et al.
THERAPIE (2018)
Timing of Onset of Adverse Cutaneous Reactions Associated With Programmed Cell Death Protein 1 Inhibitor Therapy
Leo L. Wang et al.
JAMA DERMATOLOGY (2018)
A case of lichenoid and pigmented drug eruption to acetazolamide confirmed by a lichenoid patch test
Laure Dequidt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management
John Shen et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Terbinafine-induced lichenoid drug eruption
Yue Zheng et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2017)
Lichenoid drug eruption induced by colchicine: case report
Isa An et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
PD-1 inhibitor-associated lichenoid inflammation with incidental suprabasilar acantholysis or vesiculationReport of 4 cases
Shaun Chou et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Lichenoid Drug Eruption with Prominent Nail Changes Due to Leflunomide in a 12-Year-Old Child
Caitlin May et al.
PEDIATRIC DERMATOLOGY (2017)
A Case of Cycloserine-Induced Lichenoid Drug Eruption Supported by the Lymphocyte Transformation Test
Jakyoung Kim et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2017)
Photosensitive lichenoid skin reaction to capecitabine
Rena A. Shah et al.
BMC CANCER (2017)
Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit
Fayeza Mohammed et al.
CASE REPORTS IN DERMATOLOGY (2017)
Lichenoid type cutaneous hyperpigmentation induced by nebivolol
Abdullah Nabi Aslan et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2017)
Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features
Michael T. Tetzlaff et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2017)
Lichenoid drug eruption induced by colchicine
Asli Akin Belli et al.
DERMATOLOGIC THERAPY (2016)
Unique Cutaneous Reaction to Second-and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
Anisha B. Patel et al.
DERMATOLOGY (2016)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
V. R. Belum et al.
EUROPEAN JOURNAL OF CANCER (2016)
Lichenoid drug eruption caused by imatinib mesylate in a Chinese patient with gastrointestinal stromal tumor
Jing-Ru Luo et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2016)
Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy
Kurt B. Schaberg et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions
George Jour et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort
Shelley Ji Eun Hwang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy
Veronica J. Shi et al.
JAMA DERMATOLOGY (2016)
Lichenoid reaction as a potential immune response marker of intratreatment histological response during successful vismodegib treatment for a giant basal cell carcinoma
Scott W. Fosko et al.
DERMATOLOGIC THERAPY (2015)
Photo-distributed lichenoid eruption secondary to direct anti-viral therapy for hepatitis C
Cory L. Simpson et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
Lichenoid Drug Eruption After Human Papillomavirus Vaccination
Mary E. Laschinger et al.
PEDIATRIC DERMATOLOGY (2015)
Lichenoid drug reaction to isoniazid presenting as exfoliative dermatitis in a patient with acquired immunodeficiency syndrome
B. K. Thakur et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2015)
Lichenoid Dermatitis in Three Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
Richard W. Joseph et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Prominent Alopetic Lesions of Lichenoid Drug Eruption Treated with Topical Tacrolimus
Hong Ki Cho et al.
ANNALS OF DERMATOLOGY (2014)
Imatinib mesylate-induced severe lichenoid rash
Arshdeep et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2014)
Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate
Yoshiko Kagimoto et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Photosensitive lichenoid drug eruption to capecitabine
Greg Walker et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Guanfacine-Induced Lichenoid Drug Eruption in a Child with Autism and Attention Deficit Hyperactivity Disorder
Mark Romanelli et al.
PEDIATRIC DERMATOLOGY (2014)
Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
Jae-Hyung Lee et al.
ANNALS OF DERMATOLOGY (2013)
Clinical variants of lichen planus
Gunnar Wagner et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2013)
Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin
I. Kolm et al.
CASE REPORTS IN DERMATOLOGY (2013)
Efficacy of Topical Calcineurin Inhibitors in Lichen Planus
Michael Samycia et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2012)
Lichen Planus
Laurence Le Cleach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy
E. Beccastrini et al.
CLINICAL IMMUNOLOGY (2011)
Lichenoid drug eruption due to eprosartan/hydrochlorothiacide
Ricardo Ruiz-Villaverde et al.
DERMATOLOGY REPORTS (2011)
Infliximab-Induced Lichen Planopilaris
Rosa Fernandez-Torres et al.
ANNALS OF PHARMACOTHERAPY (2010)
Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis
Jane Wu et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2010)
Chemokines in the Pathogenesis of Lichenoid Tissue Reactions
Stephan Meller et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Lichen planus-like eruptions: An emerging side effect of tumor necrosis factor-α antagonists
Adam Asarch et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Lichenoid Eruption Associated with Hydrochlorothiazide and Possible Cross Reactivity to Furosemide
Karim Aouam et al.
THERAPIE (2009)
Penicillamine-related lichenoid dermatitis and utility of zinc acetate in a wilson disease patient with hepatic presentation, anxiety and spect abnormalities
L. Leggio et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)
Lichenoid eruption associated with the use of nebivolol
Michael Bodmer et al.
ANNALS OF PHARMACOTHERAPY (2006)
Etanercept-induced lichenoid reaction pattern in psoriasis
H. Jorn Bovenschen et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2006)
Lichenoid drug eruption probably associated with rofecoxib
NA Abu-Shraie et al.
ANNALS OF PHARMACOTHERAPY (2004)
Spontaneous tolerance to terbinafine-induced lichenoid drug eruption
Y Teraki et al.
DERMATOLOGY (2004)
Photodistributed lichenoid drug eruption with rhabdomyolysis occurring during leflunomide therapy
ER de Gutierrez et al.
DERMATOLOGY (2004)
Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin)
B Sebök et al.
ACTA DERMATO-VENEREOLOGICA (2004)
Subacute Lichenoid eruption due to L-thyroxine overdosage
S Kaur et al.
DERMATOLOGY (2003)
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy
SA Devos et al.
DERMATOLOGY (2003)
Papulonodular lichenoid and pseudolymphomatous reaction at the injection site of hepatitis B virus vaccination
NG Stavrianeas et al.
DERMATOLOGY (2002)
The clinical picture - A 44-year-old man with a pruritic skin rash
R Bargout et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2001)
Lichenoid drug eruption to salsalate
ML Powell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Drug points - Lichenoid drug eruption with proton pump inhibitors
JL Bong et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
